Inspection classificationInspection ended April 22, 2026

FDA inspection of Accugenix LLC: NAI

No action indicated

FDA's record ↗

FDA classified an inspection of Accugenix LLC in Newark, DE as NAI (no action indicated). The inspection ended on April 22, 2026. Product type: Drugs.

On the record

Establishment
Accugenix LLC
Location
Newark, DE
Classification
NAI · No action indicated
Inspection ended
2026-04-22
Product type
Drugs
Fiscal year
FY2026
FDA establishment identifier (FEI)
3002920000
Source
FDA Data Dashboard ↗

The full record

An account shows the project areas inspected and whether citations were posted.

What an inspection classification is

After an inspection FDA classifies the outcome. NAI (no action indicated): no objectionable conditions were found, or none that justify further action. VAI (voluntary action indicated): objectionable conditions were found, but the agency is not prepared to take or recommend regulatory action. OAI (official action indicated): regulatory or administrative action is recommended.

More

Watch Accugenix LLC

A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.

From FDA Data Dashboard; FDA posts a classification after its review, which can be months after the inspection ended. The record may have changed since it was read.

Approve Suite is not affiliated with FDA, or with Accugenix LLC.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.